Aberrant tau forms deposited in the blood (and CSF) are a biomarker of tauopathies, Alzheimer’s disease (AD) and other dementias [51, 53, 54], Creutzfeldt-Jakob disease [55] and other brain related neuropathies [56, 57]. Here, MAPT is linked to early-onset autosomal dominant Alzheimer disease.